Literature DB >> 16314924

Understanding microtubule dynamics for improved cancer therapy.

S Honore1, E Pasquier, D Braguer.   

Abstract

Microtubules (MTs), key components of the cytoskeleton, are dynamic polymers of tubulin that form a well-organized network of polarized tube filaments. MT dynamics are highly regulated both spacially and temporally by several MT-related proteins, themselves regulated by several kinases and phosphatases via signaling cascades, and also by coordinated interactions with actin cytoskeleton and adhesion sites. Regulation of MT dynamics is crucial for mitosis, cell migration, cell signaling and trafficking. MT-targeted drugs (MTDs), which constitute a major anticancer drug family with antimitotic and antiangiogenic properties, inhibit tumor progression mainly by altering MT dynamics in both cancer and endothelial cells. Identification of proteins regulating the MT network will lead to a better understanding of tumor progression regulators and will be helpful in improving cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314924     DOI: 10.1007/s00018-005-5330-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  84 in total

1.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

2.  Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

Authors:  Giuseppe La Regina; Ruoli Bai; Willeke Rensen; Antonio Coluccia; Francesco Piscitelli; Valerio Gatti; Alessio Bolognesi; Antonio Lavecchia; Ilaria Granata; Amalia Porta; Bruno Maresca; Alessandra Soriani; Maria Luisa Iannitto; Marisa Mariani; Angela Santoni; Andrea Brancale; Cristiano Ferlini; Giulio Dondio; Mario Varasi; Ciro Mercurio; Ernest Hamel; Patrizia Lavia; Ettore Novellino; Romano Silvestri
Journal:  J Med Chem       Date:  2011-11-21       Impact factor: 7.446

3.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  Microtubule stability studied by three-dimensional molecular theory of solvation.

Authors:  Piotr Drabik; Sergey Gusarov; Andriy Kovalenko
Journal:  Biophys J       Date:  2006-10-20       Impact factor: 4.033

5.  Microtubule regulation of corneal fibroblast morphology and mechanical activity in 3-D culture.

Authors:  Areum Kim; W Matthew Petroll
Journal:  Exp Eye Res       Date:  2007-07-19       Impact factor: 3.467

6.  LC/MS identification of 12 intracellular cytoskeletal and inflammatory proteins from monocytes adherent on surface-adsorbed fibronectin-derived peptides.

Authors:  Sean T Zuckerman; Weiyuan John Kao
Journal:  J Biomed Mater Res A       Date:  2008-05       Impact factor: 4.396

7.  Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process.

Authors:  Enrique Arciniegas; Luz M Carrillo; Juan B De Sanctis; Daniel Candelle
Journal:  Cell Adh Migr       Date:  2008-01-23       Impact factor: 3.405

8.  Class III beta-tubulin is a component of the mitotic spindle in multiple cell types.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Juha Peltonen
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

Review 9.  Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.

Authors:  Chryso Kanthou; Gillian M Tozer
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

10.  Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Taradas Sarkar; Carlota Lopez Cara; Olga Cruz Lopez; Maria Dora Carrion; Delia Preti; Manlio Tolomeo; Jan Balzarini; Ernest Hamel
Journal:  Med Chem       Date:  2008-11       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.